May 13, 2020 | Audience, Authentic Ally, Bedrock, Bravely Bedrock, Commercial Team, Dynamics, Insights, Origins, Pharmaceuticals, collaboration, healthcare communications, medical affairs
The shift in dynamics between medical affairs and commercial teams
David Youds, CEO, Bedrock Group
The function of Medical Affairs has evolved over the years, and continues to do so at quite a pace. The traditional dynamic between Medical Affairs and Commercial teams has been one of restriction, with regulations on “promotional” activities. However, in more recent times there has been a shift towards an increasingly shared responsibility between Commercial and Medical Affairs teams based on mutual values of patient centricity, value propositions and the use of data.
Medical Affairs has always been a vital conduit of information both inwards and outwards. Partnerships between Medical Affairs and external stakeholders are invaluable and provide insights that can steer future medical strategy. The increasing focus of these external stakeholders on proactive communication has driven Medical Affairs teams to be more forward-looking and ensure a greater understanding of the needs and preferences of their internal and external audiences.
As a result of these shifting dynamics, and in a world with better informed audiences than ever before, the scope of deliverables, availability of new technology and the relative size of medical budgets has changed. Correspondingly, strategic input from Medical Affairs is in demand now more than ever.
As has been said many times “with great power comes great responsibility”. There is increasing responsibility for Medical Affairs to be proactive, address data gaps, be patient-focused, creative, understand channel choice, and deliver behaviour change in addition to their more traditional role in medical and scientific information. This means new skills and new internal partnerships are required.
Most importantly, Medical Affairs needs to assert itself as a strategic co-leader of any pharmaceutical product. There are too many examples of sub-optimal collaboration between commercial and medical departments, often blamed on compliance and the need for ‘firewalls’. While an element of this argument holds true, with the right mindset in place and an early start on strategic alignment across internal functions, many of these barriers can be overcome. The value of this collaborative approach for health systems, and ultimately patients, is huge.
David Youds, CEO, Bedrock Group
This content was provided by Bedrock Healthcare Communications
Company Details
Latest Content from Bedrock Healthcare Communications
Emily Wigginton, Bedrock’s Head of Client Services, explains the inspiration behind the film designed to bring more awareness to the public about rare disease.
In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.
Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.
Bedrock Healthcare Communications MD Marie Little talks through the ARISE process and the clarity it brings to clients.
Affirms Resonant’s mission to enable effective engagement in health
Read our latest article, written by Chris Barton (Strategic Solutions Director), who shares his thoughts on how pharmaceutical companies and medical communication companies, like Bedrock, can support healthcare systems to...
Learn from our Scientific Director, Stephanie Wasek, the secret to writing creative, compelling content for medical communications.
At Bedrock Healthcare Communication we are proud to help spread awareness of dementia with the ultimate goal to improve the lives of patients and carers
Just two months into the year and at Bedrock we’ve already added FOUR new people to an ever-growing team!
28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.